Please enable Javascript
17th International Myeloma Workshop (IMW 2019)
Bone Marrow MRI Versus 18F-FDG-PET/CT for Detecting Multiple Myeloma Lesions: Diagnostic Performance and Clinical Relevance
DocWire News Editors
International Myeloma Workshop 2019
|
April 24, 2023
Whole-body MRI (WBMRI) is significantly more sensitive than PET/CT at detecting bone marrow involvement (BMI) in ...
Fracture Risk Assessment in Patients with Monoclonal Gammopathy of Undetermined Significance: Value of Bone Mineral Density and Trabecular Bone Score
DocWire News Editors
International Myeloma Workshop 2019
|
October 22, 2019
Patients with gammopathy of undetermined significance (MGUS) were unable to be classified by bone mineral density (BMD) ...
Clinical and Biological Early Relapse Predictors in Multiple Myeloma: An Analysis from the MMRF CoMMpass Study
DocWire News Editors
International Myeloma Workshop 2019
|
October 22, 2019
Independent predictors of early relapse multiple myeloma (MM) include TP53 mutation, high LDH levels, amp1q and IGLL5 ...
A Tale of Two Paradigms: Fixed Duration vs Continuous Therapy in Routine Clinical Practice: An INSIGHT MM Study Analysis
DocWire News Editors
International Myeloma Workshop 2019
|
October 22, 2019
Researchers of a study presented at the 17th International Myeloma Workshop are aiming to characterize the longitudinal ...
Efficacy and Safety of Carfilzomib Pomalidomide-Dexamethasone in Relapsed and/or Refractory Multiple Myeloma: Pooled Analysis of 2 Single Arm Studies
DocWire News Editors
International Myeloma Workshop 2019
|
October 3, 2019
The triple combination of carflizomib, pomalidomide, and dexamethasone (KPd) is an effective, and well-tolerated option ...
High-dimensional Clonal Heterogeneity and Immune Landscape in Multiple Myeloma
DocWire News Editors
International Myeloma Workshop 2019
|
April 20, 2023
The results of a study presented at the 17th International Myeloma Workshop might provide the rational for predicting ...
Risk of Progression Across Age and Race for Patients with Smoldering Multiple Myeloma
DocWire News Editors
International Myeloma Workshop 2019
|
October 3, 2019
There exists a higher rate of multiple myeloma (MM) progression in younger patients with smoldering multiple myeloma ...
Fractures and Survival in Multiple Myeloma: Results from a Population-Based Study
DocWire News Editors
International Myeloma Workshop 2019
|
October 3, 2019
Multiple myeloma (MM) patients with a fracture at diagnosis have a higher risk of dying compared to patients without a ...
Single-Cell Dissection of Resistance to Anti-BCMA CAR-T Cell Therapy
DocWire News Editors
International Myeloma Workshop 2019
|
September 30, 2019
Researchers have uncovered that both T cell-intrinsic and microenvironment factors are associated with clinical response ...
Clinical Responses and Pharmacokinetics of Fully Human BCMA Targeting CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma
DocWire News Editors
International Myeloma Workshop 2019
|
September 30, 2019
This early-stage clinical study, presented at the 17th International Myeloma Workshop, exhibited the safety and efficacy ...
Determining Resistance Mechanisms in BRAF-Mutated Multiple Myeloma
DocWire News Editors
International Myeloma Workshop 2019
|
September 30, 2019
Resistance to BRAF inhibition in vitro is mediated by the two distinct mechanisms of clonal outgrowth of genetically ...
PHF19 Promotes Drug Resistance via Increased EZH2 Phosphorylation in Multiple Myeloma
DocWire News Editors
International Myeloma Workshop 2019
|
September 30, 2019
PHD finger protein 1 9(PHF19), represents a potential therapeutic target to overcome drug resistance and improve ...
Advertisement
Advertisement